Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial
Titel:
Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial
Auteur:
Ramacciotti, Eduardo Barile Agati, Leandro Calderaro, Daniela Aguiar, Valéria Cristina Resende Spyropoulos, Alex C de Oliveira, Caroline Candida Carvalho Lins dos Santos, Jessica Volpiani, Giuliano Giova Sobreira, Marcone Lima Joviliano, Edwaldo Edner Bohatch Júnior, Milton Sérgio da Fonseca, Benedito Antônio Lopes Ribeiro, Maurício Serra Dusilek, Cesar Itinose, Kengi Sanches, Suzanna Maria Viana de Almeida Araujo Ramos, Karine de Moraes, Nara Franzin Tierno, Paulo Fernando Guimarães Morando Marzocchi de Oliveira, André Luiz Malavasi Longo Tachibana, Adriano Chate, Rodrigo Caruso Santos, Marcus Vinícius Barbosa de Menezes Cavalcante, Bruno Bezerra Moreira, Ricardo Cesar Rocha Chang, Chiann Tafur, Alfonso Fareed, Jawed Lopes, Renato D